U.S. copy of GSK's Advair a step closer as Mylan files generic version

LONDON, Jan 12 (Reuters) - The arrival of cheap generic versions of GlaxoSmithKline's top-selling lung drug Advair has moved a step closer with confirmation from Mylan that it has submitted a generic version for approval.